MGC Pharmaceuticals Ltd. has signed an exclusive distribution agreement with Sciensus Rare, a part of UK health care group, Sciensus, for the distribution of CannEpil® and CogniCann® in key European territories and the UK. The agreement is for the distribution in key European territories and the UK for CannEpil®, used to treat Drug Resistant Epilepsy,…
eTurboNews amanqaku ngababhalisi kuphela. Umrhumo ngu fREE.
Ababhalisi bangena apha Cofa apha ukuze ubhalise FREE
Ababhalisi bangena apha Cofa apha ukuze ubhalise FREE
INTO ONOKUYITHATHA KWELI NQAKU:
- has signed an exclusive distribution agreement with Sciensus Rare, a part of UK health care group, Sciensus, for the distribution of CannEpil® and CogniCann® in key European territories and the UK.
- The agreement is for the distribution in key European territories and the UK for CannEpil®, used to treat Drug Resistant Epilepsy,….
- eTurboNews amanqaku ngababhalisi kuphela.
